Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Simon

Showing results (841-850 of 949) with videos related to

Pageof 95
Sort By:
Nature Reviews. Neurology|December 7, 2011
MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trialsFrederik Barkhof, Jack H Simon, Franz Fazekas, et al.
Pediatrics|January 6, 2026
Epidemiology of Pediatric Tuberculosis in the Western Cape: A Population-Based Study (2017-2023)Lauren R Brown, Mariette Smith, Cari van Schalkwyk, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2023
QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric StudiesAli Mohamed Ali, Kendra K Radtke, Anneke C Hesseling, et al.
Blood|July 8, 2011
The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in miceAnthony J Courey, Jeffrey C Horowitz, Kevin K Kim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2021
Moxifloxacin Pharmacokinetics, Cardiac Safety, and Dosing for the Treatment of Rifampicin-Resistant Tuberculosis in ChildrenKendra K Radtke, Anneke C Hesseling, J L Winckler, et al.
Vaccine|January 18, 2011
Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naïve ferretsBenoît Baras, Leon de Waal, Koert J Stittelaar, et al.
The Journal of Antimicrobial Chemotherapy|September 16, 2021
Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trialAnthony J Garcia-Prats, Elin M Svensson, Jana Winckler, et al.
Archives of Neurology|June 19, 2001
Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trialJ A Cohen, G R Cutter, J S Fischer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 7, 2017
The NAIMS cooperative pilot project: Design, implementation and future directionsJiwon Oh, Rohit Bakshi, Peter A Calabresi, et al.
British Journal of Cancer|May 17, 2007
Epirubicin-vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trialP Kerbrat, H Roché, J Bonneterre, et al.
Pageof 95

Showing results (841-850 of 949) with videos related to

Sort By:
Pageof 95
Nature Reviews. Neurology|December 7, 2011
MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trialsFrederik Barkhof, Jack H Simon, Franz Fazekas, et al.
Pediatrics|January 6, 2026
Epidemiology of Pediatric Tuberculosis in the Western Cape: A Population-Based Study (2017-2023)Lauren R Brown, Mariette Smith, Cari van Schalkwyk, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2023
QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric StudiesAli Mohamed Ali, Kendra K Radtke, Anneke C Hesseling, et al.
Blood|July 8, 2011
The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in miceAnthony J Courey, Jeffrey C Horowitz, Kevin K Kim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2021
Moxifloxacin Pharmacokinetics, Cardiac Safety, and Dosing for the Treatment of Rifampicin-Resistant Tuberculosis in ChildrenKendra K Radtke, Anneke C Hesseling, J L Winckler, et al.
Vaccine|January 18, 2011
Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naïve ferretsBenoît Baras, Leon de Waal, Koert J Stittelaar, et al.
The Journal of Antimicrobial Chemotherapy|September 16, 2021
Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trialAnthony J Garcia-Prats, Elin M Svensson, Jana Winckler, et al.
Archives of Neurology|June 19, 2001
Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trialJ A Cohen, G R Cutter, J S Fischer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 7, 2017
The NAIMS cooperative pilot project: Design, implementation and future directionsJiwon Oh, Rohit Bakshi, Peter A Calabresi, et al.
British Journal of Cancer|May 17, 2007
Epirubicin-vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trialP Kerbrat, H Roché, J Bonneterre, et al.
Pageof 95